Showing results (1491-1500 of 2,142) with videos related to
Sort By:
Pageof 215
Current Eye Research|May 10, 2016
An Experimental Animal Model of Photodynamic Optic Nerve Head Injury (PONHI)Dimosthenis Mantopoulos, Peggy Bouzika, Athanassios Tsakris, et al.World Journal of Critical Care Medicine|February 23, 2017
Intravenous vitamin C as adjunctive therapy for enterovirus/rhinovirus induced acute respiratory distress syndromeAlpha A Fowler Iii, Christin Kim, Lawrence Lepler, et al.American Journal of Surgery|February 5, 2021
Association of medicaid expansion of the Affordable Care Act with the stage at diagnosis and treatment of papillary thyroid cancer: A difference-in-differences analysisJessica Limberg, Dessislava Stefanova, Jessica W Thiesmeyer, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|December 21, 2018
Lysyl oxidase enzymes mediate TGF-β1-induced fibrotic phenotypes in human skin-like tissuesMengqi Huang, Zhiyi Liu, Lauren Baugh, et al.Neurocritical Care|November 24, 2019
Clinical Performance Measures for Neurocritical Care: A Statement for Healthcare Professionals from the Neurocritical Care SocietySarah Livesay, Herbert Fried, David Gagnon, et al.Journal of Clinical Microbiology|April 19, 2003
Detection of Ehrlichia spp., Anaplasma spp., Rickettsia spp., and other eubacteria in ticks from the Thai-Myanmar border and VietnamPhilippe Parola, Jean-Paul Cornet, Yibayiri Osée Sanogo, et al.The Journal of Pharmacy and Pharmacology|June 10, 2009
L-Carnosine: multifunctional dipeptide buffer for sustained-duration topical ophthalmic formulationsSwita R Singh, Samantha T Carreiro, Jessie Chu, et al.Annals of Vascular Surgery|November 17, 2021
The Hyperattenuating Crescent Sign Is Not Necessarily a Sign of Impending Aortic Aneurysm RuptureJordan B Stoecker, Kevin C Eddinger, Alison M Pouch, et al.The Journal of Clinical Endocrinology and Metabolism|July 15, 2025
Long Term Survivors of Anaplastic Thyroid Cancer: A Genomic Predictive ModelBenjamin C Greenspun, Daniel Aryeh Metzger, Sally Lee, et al.Clinical Ophthalmology (Auckland, N.Z.)|March 11, 2026
Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Dye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 StudyJosh Johnston, Richard Adler, Michelle Hessen, et al.Pageof 215